Moneycontrol PRO
Upcoming Event : Register for INTRAZON 3.0 India's Largest Retail Intraday Traders Online Conference
you are here: HomeNewsIndia

Coronavirus Update: India logs 45,352 new COVID-19 cases, 366 deaths

The death toll climbed to 4,39,895 with 366 fresh fatalities, according to the data updated at 8 am.

September 03, 2021 / 09:58 AM IST
India achieved its highest daily vaccination and achieved the milestone of administering one core COVID-19 vaccine doses in one day for the first time on August 27. As many as 1,00,64,032 doses of coronavirus vaccine were administered on August 27 taking the total vaccine doses administered to 63.09 crore. [Representative image]

India achieved its highest daily vaccination and achieved the milestone of administering one core COVID-19 vaccine doses in one day for the first time on August 27. As many as 1,00,64,032 doses of coronavirus vaccine were administered on August 27 taking the total vaccine doses administered to 63.09 crore. [Representative image]

With 45,352 people testing positive for coronavirus, India’s total tally of COVID-19 cases rose to 3,29,03,289, while active cases registered an increase for the third consecutive day, according to the Union Health Ministry data updated on Friday.

The death toll climbed to 4,39,895 with 366 fresh fatalities, according to the data updated at 8 am.

The active cases increased to 3,99,778 comprising 1.22 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 97.45 per cent, the ministry said.

An increase of 10,195 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India crossed the grim milestone of two crore on May 4 and three crore on June 23.

(With PTI inputs)
Moneycontrol News
first published: Sep 3, 2021 09:59 am